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ABSTRACT 1 
Food allergy is a phenotypically extremely heterogeneous group of diseases affecting multiple 2 
organs, sometimes isolated, sometimes simultaneously, with severity of reactions ranging from 3 
mild local to full-blown anaphylaxis. Mechanistically, it is defined as a Th2-driven immune 4 
disorder in which food-specific IgE antibodies are at the basis of immediate type adverse 5 
reactions. The sites of sensitization and symptoms do not necessarily overlap. Food allergy is 6 
often confused with other immune (e.g., celiac disease) and non-immune (e.g., lactose 7 
intolerance) food hypersensitivities. To reliably diagnose food allergy, a careful history 8 
(immediate type reactions) needs to be complemented with demonstration of specific IgE 9 
(immune mechanism) and confirmed by an oral challenge. Co-factors such as exercise, 10 
medication, and alcohol may help trigger food allergy and further complicate accurate diagnosis. 11 
Where food extract-based diagnostic tests are poorly correlated to symptom severity, new 12 
generation molecular diagnostics that measure IgE against individual food allergens provide 13 
clinicians and patients with more reliable symptom severity risk profiles. Molecular diagnostics 14 
also support establishing whether food sensitization originates directly from exposure to food or 15 
indirectly (cross-reactivity) from pollen sensitization. Epidemiological surveys have indicated that 16 
allergy to peach primarily originates from peach consumption in Europe, whereas in China it is 17 
the result of primary sensitization to mugwort pollen, in both cases mediated by an allergen 18 
molecule from the same family. Epidemiological surveys give insight into the etiology of food 19 
allergy, in the size of the problem (prevalence) and the risk factors involved, together supporting 20 
evidence-based strategies for prevention. Over the past decade, food allergy has increased in 21 
the affluent world. Economic growth and urbanization in upcoming economies are likewise 22 
expected to lead to increased prevalence of food allergies, sometimes to different foods due to 23 
dietary habits. Molecular allergology and biotechnology now offer the possibility to combat the 24 
increasing burden of food allergy by developing safe immunotherapies for food allergy, using 25 
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hypo-allergenic mutant recombinant molecules. The first clinical trials to evaluate such 1 
approaches are underway.  2 
 3 
4 
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INTRODUCTION 1 
An important aspect of evaluating the safety of genetically modified (GM) crops for use as food 2 
and animal feed is a risk assessment of potential effects on human health and the environment.  3 
This risk assessment is based on evaluations of allergenicity, toxicity, and unintended adverse 4 
effects.  The current state of the science for addressing the safety of protein allergens utilizes a 5 
weight-of-evidence approach, as outlined by the Codex Alimentarius Commission (Alinorm 6 
03/34A), recognizing that no single endpoint is sufficiently predictive of the allergenic potential of 7 
a novel protein.   8 
 9 
In April 2013, the China National Centre for Food Safety Risk Assessment, the Key Laboratory 10 
on Food Safety Risk Assessment of the China Ministry of Health, the International Life Sciences 11 
Institute (ILSI) Focal Point in China, the Protein Allergenicity Technical Committee (PATC) of 12 
the ILSI Health and Environmental Sciences Institute (HESI), and the ILSI International Food 13 
Biotechnology Committee (IFBiC) co-sponsored a “Food Allergy and Safety Assessment 14 
Workshop” in Beijing, China.   15 
 16 
The objectives of the workshop were to describe the state of the science in assessing protein 17 
allergenicity, toxicity, and composition analysis of biotechnology-based food crops; identify and 18 
discuss accepted standards as well as innovative approaches being utilized to address clinical 19 
allergy; and discuss the safety framework for GM crops, the regulatory approval processes, and 20 
how they are implemented globally.  Clinicians reviewed allergy prevalence and study design 21 
strategies.  22 
 23 
The focus of this paper is on the food allergy component of the workshop. 24 
 25 
  26 
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FOOD ALLERGY:  INTRODUCTION, ETIOLOGY, AND MECHANISMS 1 
[Lars Poulsen] 2 
The symptomatology of food allergy is quite variable, and often symptoms originate from more 3 
than a single organ, including the oral cavity (oral allergy syndrome), the skin (urticaria and 4 
exacerbation of atopic eczema), the respiratory system (rhinitis and asthma), the 5 
gastrointestinal system (nausea, vomiting, abdominal pain, diarrhea), and additional symptoms 6 
such as conjunctivitis, angioedema, and generalized anaphylaxis. It is generally believed that 7 
whole food allergen proteins either act on the mucosa in the intestinal tract or may be absorbed 8 
systemically in a bioactive form.  9 
 10 
The fact that most people ingest large amounts and perhaps even high numbers of foods every 11 
day makes the diagnostic process complicated. Depending on the affected organs and the 12 
symptoms, many inflammatory and other disease states may have to be excluded before the 13 
food allergy diagnosis is considered. If the anamnesis suggests a link between food or drink 14 
intake and symptoms, it may be helpful to consider that food allergy is but a subgroup of 15 
adverse reactions to foods (Figure 1).  16 
 17 
First, it is important to exclude food poisonings or infections, i.e., if more than a single person 18 
has reacted to the same exposure to food, it is likely to be a mechanism other than allergy. In 19 
this respect, it is important to remember, that allergy-like symptoms may also be a part of the 20 
pattern of a food-borne poisoning such as for scombroid poisoning, a dramatic example of an 21 
outbreak (Demoncheaux et al., 2012), where the active substance is histamine stemming from 22 
decarboxylation of the amino acid histidine in, for example, fish during putrefaction. 23 
 24 
Another differential diagnosis comprises genetic or acquired deficiencies in metabolism, of 25 
which lactase deficiency (Jarvela et al., 2009) is probably the most common. In adult and 26 
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adolescent patients, alcohol intolerance may be another important diagnosis in this respect, but 1 
alcohol could also be a co-factor in eliciting food allergy by reducing the threshold dose to which 2 
the patient reacts. 3 
 4 
Physiological and pathophysiological reactions may be mediated via taste (Negri et al., 2011), 5 
and this may lead to conditional behavior, such as aversion, where stimulation of taste receptors 6 
initiates a central nervous reflex (Spector and Glendinning, 2009) that may ultimately lead to 7 
reactions that could be misinterpreted as food allergy. This, in combination with a patient's 8 
potential psychological fear of ingesting a food believed to previously causing a severe reaction, 9 
is the main reason for employing double blind placebo controlled challenges in the diagnosis of 10 
food allergy.  11 
 12 
If the considerations and exclusions of the above-mentioned differential diagnoses lead to the 13 
tentative conclusion that the patient reacts to amounts of food that would be tolerated by most 14 
individuals in the population, the diagnosis of food hypersensitivity may be reached. Such a 15 
diagnosis can be strongly supported by a positive challenge with the offending food, but it is 16 
important to emphasize that the positive challenge rarely in itself can suggest the disease 17 
mechanism. By definition, food allergy is a food hypersensitivity that has an immunological 18 
background, whereas non-immunological food hypersensitivity (formerly described as food 19 
intolerance) depends on other, not necessarily known, mechanisms. Since the latter disease 20 
states are not well described in terms of pathophysiology, it is mandatory to establish a clinically 21 
proven diagnosis of food hypersensitivity and not rely only on laboratory or other paraclinical 22 
tests (Ortolani et al., 1999; Bindslev-Jensen et al., 1994). 23 
  24 
This definition of food allergy (Johansson et al., 2001) [see Burks et al. (2012) for discussion 25 
and reference to further guidelines for classification] leads to inclusion of diseases, such as 26 
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celiac disease or rare conditions such as food-induced nickel allergy (systemic contact 1 
dermatitis) (Menne et al., 1994) besides IgE-mediated food allergy. A number of conditions, 2 
such as eosinophilic esophagitis or gastroenteritis IgE-mediated food allergy, may play a role in 3 
worsening of symptoms, as well as driving the pathology. The reader is referred to the specialty 4 
literature, but in terms of diagnosis, it is important to establish whether a specific food actually 5 
plays a role in patients with these diseases. 6 
 7 
While total-IgE may be an indicator of general atopy, it is rarely, if ever, helpful in discriminating 8 
persons with or without food allergy (Boyce et al., 2010). Likewise have acute measurements 9 
during challenge such as plasma-histamine or tryptase not been documented to be of large 10 
clinical value (Sampson et al., 2012). Thus the most important single factor in food allergy is 11 
specific IgE directed against the food allergens.  IgE is situated on mast cells and, by allergen 12 
cross-linking, mediators are released which forms the basis of the acute symptoms mentioned 13 
above. IgE and the mast cells in the skin also form the basis of diagnosis made both by the skin 14 
prick test which is the major diagnostic tool in addition to blood samples. 15 
 16 
The production of IgE by B-lymphocytes that have undergone an isotype switch to IgE-17 
producing plasma cells (Poulsen and Hummelshoj, 2007) is believed to be governed by the 18 
dominating CD4+ T-cell in allergy: the Th2-cell which expresses the cytokines IL-4, IL-5, IL-13, 19 
and likely also IL-9 and IL-22. However, the migratory patterns of T-cells in allergy and in 20 
particular food allergy are much less clear. Depending on the manifestation of clinical symptoms 21 
in different organs such as the gut, the skin, or the airways, T-cells may often be found in each 22 
of these inflammatory foci with different characteristics. Whether these cells are the primary 23 
drivers of the disease or secondary to the primary sensitization is not known, but the 24 
generalized IgE-immune response most often seen in food allergies could suggest that the 25 
initiation of the food allergic immune reaction is not always related to the organ in which 26 
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elicitation takes place. In this respect, it is interesting that recent studies of food allergy applying 1 
the tetramer technique for enumerating allergen specific T-cells have found relatively few gut-2 
specific (α4β7+) T-cells compared to a higher frequency of skin-specific (CLA+) T-cells  (Chan 3 
et al., 2012), although varying results have been found by others (DeLong et al., 2011).  Future 4 
studies will have to further address the role of the allergen-specific CD4+ T-cells and their 5 
localization. It is likely that such studies will help in increasing our understanding of the 6 
sensitization process, which may ultimately lead to a better primary prevention of food allergy. 7 
 8 
GLOBAL PREVALENCE OF FOOD ALLERGY   9 
[Gary WK Wong] 10 
Allergic disorders including asthma, allergic rhinitis, atopic dermatitis, and food allergies are very 11 
common in westernized societies. In the developed world, about one third of children are 12 
suffering from at least one or more of these allergic conditions. The exact causes of food 13 
allergies are unknown and the only preventive treatment for this potentially fatal disorder is 14 
avoidance of the offending food. Epidemiology studies are important to define the scope of the 15 
problem and may reveal possible clues for the possible etiologies of food allergies. 16 
 17 
Followed by the increase in the prevalence of asthma and allergic rhinitis, the rise in food allergy 18 
appears to be more apparent in the past decade (Prescott and Allen, 2011). Food allergy is 19 
often the first manifestation of the “atopic march.” From prospective birth cohort studies, early 20 
sensitization to food allergens has been found to be an important factor predicting subsequent 21 
development of other forms of allergies (Illi et al., 2006; Guilbert et al., 2004). In the last few 22 
decades, the prevalence of asthma has been increasing steadily, and recent studies have found 23 
that the prevalence has reached a plateau in countries where prevalence rates are high. 24 
However, the increase in food allergies appears to be a recent event, and it has been described 25 
as the “second wave” of increase following the increase of asthma (Prescott and Allen, 2011). 26 
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Both population-based and hospital surveys have shown that food allergies and food-induced 1 
anaphylaxis are on the rise in the last decade. However, there were wide variations in the 2 
methodologies in the studies of food allergies across the world making comparison of the 3 
available data rather difficult. Furthermore, many studies use questionnaires alone and did not 4 
include any objective measures or validation by food challenges. Subjects and parents were 5 
likely to over-report the possibility of adverse food reactions, and some of these reactions may 6 
not be related to true food allergies. A recent meta-analysis has clearly shown that the use of 7 
objective measurement and food challenge to confirm the diagnosis of food allergies would 8 
result in a much lower prevalence of food allergies (Rona et al., 2007). This is why the 9 
EuroPrevall research consortium was developed and the work was funded by the European 10 
Union. The consortium used standardized instruments to evaluate the epidemiology of food 11 
allergies in many European and several other non-European countries (Kummeling et al., 2009; 12 
Wong et al., 2010).  13 
 14 
Because dietary patterns vary in different parts of the world, it is not surprising that there are 15 
marked variations in the prevalence as well as the patterns of food allergies. Globally, egg, milk, 16 
peanut, and tree nuts and fruits are the most common allergens, followed at a distance by 17 
shrimp and fish (Burney et al., 2010, 2013). In the US alone, there are more than 30,000 18 
episodes of food-induced anaphylaxis, resulting in more than 150 deaths every year (Sampson, 19 
2003). In a recent study based on hospitalization data from Australia, food-induced anaphylaxis 20 
resulting in hospital admission increased by almost 4-fold from 1994 to 2005 in children under 21 
four years of age (Poulos et al., 2007). Furthermore, the prevalence of food allergies confirmed 22 
by food challenge has been found to be as high as 10% in Australian infants (Osborne et al., 23 
2011). Three telephone surveys using the same methodology conducted in the US over the past 24 
12 years has also documented increases in peanut allergy by 3-fold in children less than 18 25 
years of age (Sicherer et al., 2010). Research into the exact reasons for such a dramatic rise is 26 
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urgently needed. Furthermore, there is evidence that the natural history of food allergy has 1 
changed. In the past, most children with milk allergy would be able to tolerate milk intake by the 2 
time they reached school age. A study from the US suggested that cow’s milk allergy is more 3 
likely to persist into adolescents (Skripak et al., 2007).  4 
 5 
In Asia, food allergies are relatively uncommon with the exception of highly developed places 6 
like Japan, Singapore and Hong Kong. As dietary intake varies widely among the Asian 7 
countries, it is not surprising that the patterns of food allergies are different among different 8 
ethnic groups. Shrimp allergy has been reported to be rather common in Singapore, Thailand, 9 
and Hong Kong (Leung et al., 2009). One intriguing finding is that peanut allergy is very 10 
uncommon in the Chinese populations despite wide-spread consumption of peanuts in China. 11 
Furthermore, Chinese children from Hong Kong have significantly higher prevalence of 12 
sensitization and reported food allergies when compared with children from mainland China. It is 13 
highly likely that some of the protective factors are lost along with the process of urbanization. 14 
Identification of these factors and understanding of the underlying mechanisms are important for 15 
future development of possible primary preventive strategies against this ‘epidemic’ of food 16 
allergies. 17 
 18 
FOOD ALLERGY: DIAGNOSIS AND CLINICAL ASSESSMENT 19 
[Barbara Ballmer-Weber] 20 
In unstructured interviews, up to 30% of the general population reports to suffer from a food 21 
allergy, sensitisation to food extracts can be measured in up to 20%, and, according to recent 22 
population surveys, true food allergy affects 1% to 10% (Rona et al., 2007). These figures 23 
clearly summarise the difficulties clinicians are confronted with if they intend to diagnose a food 24 
allergy.  25 
 26 
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Diagnosis of food allergy includes the establishment of a reliable link between the clinical history 1 
of an adverse reaction to one or several foods as reported by the patient and the immunological 2 
basis of this reaction. The first step in assessment of patients with adverse reactions to foods is 3 
a careful case history. The case history is not reliable as a sole criterion to establish the 4 
diagnosis of food allergy, but it might provide the clinician with an estimation of the severity of 5 
the allergic response. The most frequent symptom of food allergy is oral contact urticaria (i.e., a 6 
swelling and itching of the oral mucosa immediately after contact with the allergenic food), which 7 
is a mild reaction. Systemic reactions may involve one or more target organs, including the skin, 8 
the gastrointestinal and upper/lower respiratory tracts, and the cardiovascular system. 9 
Anaphylaxis is the most severe manifestation of food allergy and a medical emergency. It is 10 
defined as a generalized, potentially lethal allergic reaction. Recently, a detailed definition 11 
establishing diagnostic criteria for anaphylaxis has been published (Sampson et al., 2006).  12 
 13 
As a next step, specific IgE antibodies to the suspected foods are measured by in vitro or skin 14 
testing to link the clinical reaction with the IgE-mediated pathophysiology. These diagnostic 15 
tests, however, only indicate the presence of food-specific IgE antibodies; they do not establish 16 
the diagnosis of food allergy. To finally prove the clinical relevance of the reported history and 17 
the detected food-specific IgE, a positive food challenge is often needed. In case of an 18 
anaphylactic reaction – if fulfilling the diagnostic criteria - clinicians try to omit confirmatory food 19 
challenges.  20 
 21 
The quality of extract-based diagnostic testing is among other factors dependent on the 22 
pathogenesis of the food allergy (Steckelbroeck et al., 2008). In infancy, food allergy is most 23 
frequently the result of primary sensitisation to food allergens over the gastrointestinal tract and 24 
directed to digestion-resistant food allergens. A hallmark of adult food allergy is the high 25 
prevalence of secondary food allergy, where the primary sensitization is directed to an inhalant 26 
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allergen (i.e., pollen). The food allergen is recognized by these inhalant allergen-specific IgEs 1 
due to a high structural homology between the food and the inhalant allergen on the basis of 2 
cross-reaction. Usually the sensitivity of food extract-based diagnostic testing is higher in 3 
primary than in cross-reactive food allergy. In primary food allergy, it has been observed at least 4 
for a limited number of foods that higher levels of allergen-specific IgE are associated with an 5 
increased likelihood of allergic reactions under provocation (so called 95% positive predicative 6 
values). This procedure, however, is not precise and, most importantly, does not predict the 7 
severity of the allergic response to foods (Wang and Sampson, 2011). 8 
 9 
Assessment of a food allergic patient also includes factors which might have influenced the 10 
severity of the allergic response. Factors which might enhance the allergic reactions to foods 11 
are physical exercise, concomitant intake of nonsteroidal anti-inflammatory drugs, beta-blocking 12 
agents, and alcohol. Another important factor which influences the allergic response is the dose 13 
or amount of the ingested allergenic food. Titrated, double-blind, placebo-controlled food 14 
challenge studies have provided important knowledge on the dose effect on the development of 15 
allergic symptoms in tested individual patients. Very low doses of the investigated food not 16 
leading to allergic symptoms indicate that there is a NOAEL (no observed adverse effect level), 17 
i.e., an amount of the allergenic food that is safe for the individual patient (Taylor et al., 2002). 18 
With increasing doses, patients often develop subjective or mild symptoms as the first 19 
manifestation of the food allergic response, whereas more severe and systemic symptoms 20 
usually occur at higher doses (Ballmer-Weber et al., 2007; Mackie et al., 2012).  21 
 22 
As observed in many recent studies, allergy to a particular food may give rise to differentially 23 
severe symptoms depending on which precise allergen component(s) the individual is 24 
sensitized to (Lidholm et al., 2006, Ballmer-Weber et al., 2011). The increasing knowledge and 25 
availability of allergen components from various foods enables a detailed analysis of 26 
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sensitisation profiles in individual patients and a comparison of such sensitisation patterns with 1 
the clinical presentation. This concept has been defined as “Component Resolved Diagnostics” 2 
(CRD). For example, the predominant sensitisation to lipid transfer proteins (LTPs) in Rosaceae 3 
fruit or hazelnut allergic individuals in the Mediterranean area is often accompanied by a history 4 
of systemic food reactions.  This is rarely the case in northern European populations where the 5 
sensitisation to Rosaceae fruits or hazelnut is characteristically directed to Bet v 1-related food 6 
allergens (Ballmer-Weber et al., 2002; Fernandez-Rivas et al., 2006; Hansen et al., 2009).  7 
 8 
Of the major peanut seed storage proteins, the 2S albumin Ara h 2, appears to be a particularly 9 
important marker of primary peanut sensitisation (Nicolaou et al., 2010). Other allergen 10 
components that hold promise as risk markers for potentially severe allergic reactions include 11 
omega-5 gliadin (Tri a 19), showing association to wheat-dependent exercise-induced 12 
anaphylaxis, and actinide (Act d 1) in kiwi allergy or Gly m 5 (beta-conglycinin) and Gly m 6 13 
(glycinin) in soy allergy (Takahashi et al., 2012; Le et al., 2013; Holzhauser et al., 2009). 14 
 15 
COMPONENT-RESOLVED DIAGNOSIS OF PEACH AND MUGWORT ALLERGY AND 16 
CROSS-REACTIVITY IN CHINA 17 
[Zhong-shan Gao] 18 
Peach is one of the most frequently reported fruits causing allergy in China, and cross reactivity 19 
among Rosaceae fruits is also observed. Mugwort pollen allergy is dominantly prevalent in most 20 
parts of China except for south and east coastal regions where mugwort pollen exposure load is 21 
very low.  A number of foods (peach, beans, peanut, sunflower seed) have been reported to 22 
produce cross-reactive allergic reactions when consumed by Chinese mugwort allergic patients 23 
(Gao et al., 2013; Wen and Ye, 2002). In Europe, at least 4 and 6 allergenic proteins have been 24 
identified for peach fruit and mugwort pollen, respectively (Chen et al., 2008; Wopfner et al., 25 
2005), and a few component ImmunoCAPs are commercially available.  To identify the main 26 
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allergens of peach and mugwort pollen in China, both extract and single components of 1 
ImmunoCAPs were used to test 70 sera from peach and/or mugwort allergy patients (Gao et al., 2 
2013). They found the LTP Pru p 3 is a major allergen, with the mean IgE response to Pru p 3 3 
being very similar to that of peach, indicating the relative importance of peach LTP. It seems to 4 
be a primary sensitizer in a smaller group in south China, which is similar to “typical 5 
Mediterranean” peach allergic patients (Fernandez-Rivas et al., 2003; Zuidmeer and van Ree, 6 
2007). The virtual absence of birch pollen in China is reflected by the very low frequency of 7 
recognized Pru p 1. The results also suggested that high exposure to mugwort pollen in north 8 
China results in strong IgE responses to Art v 3 that cross-react with Pru p 3, thereby causing 9 
peach allergy. ImmunoCAP inhibition experiments with Art v 3 and Pru p 3 recombinant 10 
allergens clearly support the dichotomy of the population of Chinese peach allergic patients: a 11 
larger group of peach allergic patients with primary sensitization to mugwort LTP, and a smaller 12 
group of patients with primary sensitization to peach LTP. With CAP inhibition experiments, 13 
there was complete inhibition of IgE binding to Pru p 3 by Art v 3 in the former group, and the 14 
absence of significant reverse inhibition. In the latter group, the results of the inhibition 15 
experiments were close to a mirror image. In conclusion, significant exposure to mugwort pollen 16 
gives rise to a peach allergy phenotype that is LTP-associated pollen-sensitization driven 17 
allergy. It may also imply that LTP from other foods such as beans and peanut are potential 18 
relevant allergens. There is a great need to identify food allergen molecules using modern 19 
techniques. 20 
 21 
INNOVATIVE APPROACHES FOR IMMUNOTHERAPY OF FOOD ALLERGY 22 
[Ronald van Ree] 23 
The FAST project ((Food Allergy Specific ImmunoTherapy) is a seven-year project funded 24 
under the 7th Framework Program of the European Union, aiming at the development of a safe 25 
and effective treatment of food allergies (Zuidmeer-Jongejan et al., 2012). It targets persistent 26 
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and severe allergy to fish and fruit. Besides persistence and severity, this choice is based on 1 
prevalence and the importance of these foods for a healthy diet. Classical allergen-specific 2 
immunotherapy (SIT) for treatment of food allergy using subcutaneous injections with food 3 
extracts has proven to be effective but too dangerous due to anaphylactic side-effects. In the 4 
1990s, subcutaneous immunotherapy was evaluated for the treatment of peanut allergy, but 5 
side-effects were so frequent and severe that this program was abandoned (Oppenheimer et 6 
al., 1992; Nelson et al., 1997). It is relevant to realize that treatment was carried out with 7 
unmodified aqueous peanut extract. FAST aims to develop a safe alternative by replacing 8 
aqueous food extracts with hypo-allergenic recombinant major allergens, the active ingredients 9 
of SIT. On top of that, to further increase safety, the hypo-allergens will be adsorbed to 10 
aluminium-hydroxide. Both severe fish and fruit allergy are dominated by a single major 11 
allergen, parvalbumin for fish and LTP for fruit. This makes development of a novel 12 
biotechnological product feasible. In the first part of the project, several approaches were 13 
evaluated for achieving hypo-allergenicity. 14 
 15 
For parvalbumin, an allergoïd (glutaraldehyde modification) and a mutant lacking the molecule’s 16 
Ca2+-binding capacity were investigated. The starting point was parvalbumin from carp, Cyp c 17 
1. Both modified molecules proved to be highly hypo-allergenic, but for further development the 18 
mutant was selected (Swoboda et al., 2007). The molecule was produced under GMP 19 
conditions, successfully underwent toxicity testing in laboratory animals, and is now being 20 
evaluated in a first-in-man safety trial (Phase I/IIa).  When the outcome is positive, it will be 21 
followed shortly by an efficacy trial (Phase IIb). 22 
 23 
For LTP, the major allergen from peach, Pru p 3, was chosen because this is considered the 24 
most relevant allergenic LTP. In the first part of the project, an allergoïd (glutaraldehyde 25 
modification), a reduced and alkylated version and a mutant lacking the eight cysteines typically 26 
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seen in LTPs (both destroying LTP’s four disulfide bridges), a mutant with mutated surface-1 
exposed IgE epitopes, and a wild-type LTP from a poorly allergenic fruit (strawberry) were used. 2 
The two versions lacking disulfide bridges proved to be extremely hypo-allergenic but poorly 3 
immunogenic. The surface mutant and the strawberry LTP were hypo-allergenic for some but 4 
not for other patients. Based on the overall analysis, none of the molecules were considered 5 
good candidates for further development. Three new molecules are now under development. 6 
Preliminary results from these analyses are promising. The most appropriate molecule will soon 7 
be selected and then produced under GMP conditions. After toxicity testing, hypo-allergenicity 8 
will then be tested in a skin-prick test trial. 9 
 10 
In conclusion, a sub-cutaneous treatment for fish allergy is now in the process of clinical testing. 11 
The treatment of fruit allergy will follow at a later stage. 12 
 13 
DISCUSSION 14 
Safety assessment of GM foods includes evaluating the potential risk of allergenicity. A good 15 
understanding of food allergy is a prerequisite for this type of assessment. The pivotal role of 16 
specific IgE antibodies in food allergy determines the focus of the assessment. Knowing which 17 
proteins in food bind IgE is vital information. A regularly updated and peer-reviewed database 18 
with sequence data of established or putative allergens is the primary tool used to evaluate 19 
whether a candidate transgene harbors the risk of being an allergen (www.allergenonline.org). 20 
Being from a known allergenic source or having significant homology to an established or 21 
putative allergen in the database warrants serum screening of the transgene’s protein product 22 
using serum of subjects being sensitized to the allergenic source or to the homologous allergen. 23 
In depth knowledge of the proteins binding IgE and of the properties of IgE antibodies against 24 
them has increased enormously with the advent of molecular allergology. The importance of 25 
molecular allergology for assessment of GM foods cannot be underestimated. Being able to 26 
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establish the clinical relevance of IgE antibodies that can vary from no relevance (e.g., IgE 1 
against plant glycans) to a risk factor for severe systemic reactions (e.g., IgE antibodies against 2 
the major peanut allergen Ara h 2) will further help robust risk assessment. Establishing whether 3 
IgE is likely to bind to a transgenic protein is becoming more and more feasible. On the other 4 
hand, science cannot yet predict whether a protein has an increased chance of inducing IgE, 5 
i.e., whether a protein has the potential to sensitize. The answer to the question “what makes an 6 
allergen an allergen?” is still unknown.  Additional research is needed to arrive at an answer that 7 
warrants including the risk of being a sensitizer into the protocols to assess the allergenic risk of 8 
GM foods. 9 
 10 
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 1 
Figure 1.  Food allergy is a subgroup of adverse reactions to foods. 2 
